Antiepileptic Drugs

Portada
René H. Levy
Lippincott Williams & Wilkins, 2002 - 968 páginas
The thoroughly revised, updated Fifth Edition of this classic is the m ost comprehensive, current, and authoritative reference on all anticon vulsants available today. This edition features detailed profiles of n ewer drugs--including levetiracetam, oxcarbazepine, tiagabine, topiram ate, and zonisamide--and new chapters on use of antiepileptic drugs in children and during pregnancy. Drugs are covered in alphabetical ord er and in an easy-to-follow format: mechanisms of action; chemistry, b iotransformation, and pharmacokinetics; interactions; clinical efficac y and use; and adverse effects. Coverage of clinical use includes none pileptic and psychiatric disorders where appropriate. This edition has been trimmed to manageable size by shortening chapters on older, less frequently used drugs.
 

Comentarios de la gente - Escribir un comentario

No encontramos ningún comentario en los lugares habituales.

Contenido

85
11
J Steven Leeder PharmD PhD Associate Professor
23
Roger J Porter MD Vice President Clinical Pharmacol Bernd Schmidt MD PhD Head Department of Neurol
49
Adverse Effects 528 70 Methsuximide 665
72
Contributing Authors xi 12 Antiepileptic Drug Use in Women
132
Epilepsy in the Elderly
149
GENERAL PRINCIPLES 1
156
Principles of Antiepileptic Drug Action 3 Brian K Alldredge
169
Adverse Effects 408 Disorders
522
Methylphenobarbital
541
Isabelle RagueneauMajlessi MD Research Associate logical Diseases Shizuoka Japan
581
R Eugene Ramsay MD Professor of Neurology and Psy
611
Meir Bialer PhD MBA David H Eisenberg Professor of Epilepsy Research and Education Program College
646
William J Giardina PhD Associate Research Fellow Washington DC
675
PHENYTOIN AND OTHER William J Giardina
681
Mechanisms of Action 551 Kenneth W Sommerville and Stephen D Collins
691

Discovery and Preclinical Development
179
H Steve White José H Woodhead Karen S Wilcox Robert L Macdonald
187
Gail D Anderson and John W Miller
206
19 Adverse Effects
215
SECTION III CARBAMAZEPINE 2 25
227
Robert L Macdonald
236
Combination Therapy and Drug Interactions 96 Edoardo Spina
247
Laboratory Monitoring of Antiepileptic Drugs 103 Colleen J Wurden and René H Levy
262
Maurice Dickins PhD Senior Scientist Drug Metabo
349
Pryor RN BSN Nurse Researcher Department City Iowa
354
278
419
Adverse Effects 285 Doru Georg Margineanu and Henrik Klitgaard
429
Charles P Taylor 44 Mechanisms of Action
451
Chemistry Biotransformation Pharmacokinetics Michael J McLean
459
Clinical Use 340 Meir Bialer
466
Adverse Effects 354 49 Adverse Effects
479
PHENOBARBITAL AND OTHER
490
Chemistry Biotransformation and Richard W Olsen
496
Interactions with Other Drugs 380 Gail D Anderson
504
Clinical Efficacy and Use in Epilepsy 389 J Steven Leeder
514
Chemistry and Biotransformation 565 Kenneth WZ Sommerville
698
Interactions with Other Drugs 581 Reetta Kälviäinen
705
Clinical Efficacy and Use in Epilepsy 591 Kenneth W Sommerville
711
600
719
Fosphenytoin 611 Dennis R Doose and Anthony J Streeter
727
Pryor and R Eugene Ramsay
735
Edoardo Spina MD PhD Associate Professor Section of Clinical Development R W Johnson Pharmaceutical
740
Primidone 621
753
SUCCINIMIDES 637 82 Adverse Effects
760
Mechanisms of Action 639
767
Clinical Efficacy and Use in Epilepsy 652 84 Chemistry Biotransformation
780
Safety Monitoring of Antiepileptic Drugs 112 Pierre Loiseau
827
Swann MD Pat R Rutherford Jr Professor and Missouri
828
90
855
91
867
93
873
Adverse Effects
892
96
901
Subject Index
929
Derechos de autor

Términos y frases comunes

Información bibliográfica